Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Transmedics Group Inc
(NQ:
TMDX
)
80.61
+2.03 (+2.58%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Transmedics Group Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
1 Top Growth Stock Down 56% to Buy After Its Recent Pullback
November 26, 2024
This growth stock has been on my watchlist for a while and might soon be included in my portfolio.
Via
The Motley Fool
2 Hypergrowth Stocks That Are Screaming Buys in November
November 23, 2024
Via
The Motley Fool
This HCA Healthcare Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
November 22, 2024
Via
Benzinga
Looking Into TransMedics Gr's Recent Short Interest
November 21, 2024
Via
Benzinga
Jim Cramer Likes Devon Energy, But Calls Another Stock 'Far Superior'
November 20, 2024
Amphenol (APH) is a terrific stock, reporting better-than-expected earnings, while Cramer prefers CTRA over DVN and doesn't see potential in TMDX.
Via
Benzinga
Navigating 11 Analyst Ratings For TransMedics Gr
November 18, 2024
Via
Benzinga
This Is What Whales Are Betting On TransMedics Gr
October 30, 2024
Via
Benzinga
Beyond The Numbers: 13 Analysts Discuss TransMedics Gr Stock
October 29, 2024
Via
Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $7,000 Today
October 28, 2024
Via
Benzinga
Is TransMedics Group Stock a Buy?
November 15, 2024
This organ transplant specialist is down, but still has plenty of signs of life.
Via
The Motley Fool
Down 52%, Is TransMedics Stock a Buy on the Dip?
November 09, 2024
Sales growth is tapering off for this provider of delivery services for transplant organs.
Via
The Motley Fool
Scott+Scott Attorneys at Law LLP Alerts Investors of Its Investigation into TransMedics Group, Inc. (NASDAQ: TMDX)
November 07, 2024
From
Scott+Scott Attorneys at Law LLP
Via
Business Wire
Why TransMedics Stock Plunged in October
November 07, 2024
The organ transplant specialist posted disappointing results in its third-quarter report.
Via
The Motley Fool
1 Top Growth Stock Down 50% to Buy After Its Recent Pullback
November 04, 2024
TransMedics quickly became the leader in liver, heart, and lung transplants, but its third-quarter earnings left the market worried. Here's why I believe its pullback in share price is an opportunity.
Via
The Motley Fool
Stock Market Retreats Before Election Day; Microsoft, Apple, Amazon, Google, Meta In Focus: Weekly Review
November 01, 2024
The major indexes declined, but haven't fallen apart.
Via
Investor's Business Daily
3 Stocks Well Below 52-Week Highs With Strong Growth Projections
November 01, 2024
These three stocks are trading deeply below their 52-week highs, and analyst project them to see big increases in earnings and revenue over coming years.
Via
MarketBeat
Topics
Immigration
Exposures
Immigration
TMDX INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Announces Investigation into TransMedics Group, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
October 30, 2024
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
Gold Gains 1%; Phillips 66 Shares Fall After Q3 Results
October 29, 2024
Via
Benzinga
Organ Transplant MedTech TransMedics Q3 Performance Disappoints, Analyst Outlines Investor Worries
October 29, 2024
TransMedics Group shares fall as Q3 EPS misses estimates; revenue rises 64% but falls short of consensus. Analysts cut price targets, citing weaker transplant volumes.
Via
Benzinga
Nasdaq Surges Over 100 Points; Pfizer Earnings Top Views
October 29, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 29, 2024
Via
Benzinga
These Analysts Cut Their Forecasts On TransMedics Group Following Weak Results
October 29, 2024
Via
Benzinga
TransMedics Stock Crashes After Earnings Disappointment. Time to Load Up the Boat?
October 29, 2024
Is this the buy-the-dip opportunity investors have been waiting for?
Via
The Motley Fool
TransMedics Group Posts Weak Results, Joins Harmonic, Crocs, D.R. Horton And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
October 29, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 29, 2024
Via
Benzinga
Boot Barn To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Tuesday
October 29, 2024
Via
Benzinga
Why VF Corp Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket
October 29, 2024
Via
Benzinga
INVESTIGATION ALERT (NASDAQ:TMDX): DiCello Levitt LLP Is Investigating Investor Claims Against TransMedics Group, Inc. and Encourages TMDX Investors with Losses to Contact the Firm
October 28, 2024
From
DiCello Levitt LLP
Via
GlobeNewswire
TransMedics, F5 Lead Big After-Hours Earnings Winners, Losers
October 28, 2024
With earnings season in full swing, big movers abound.
Via
Investor's Business Daily
TransMedics Group Stock Sinks On Q3 Earnings: The Details
October 28, 2024
TransMedics Group shares are trading lower in Monday's after-hours session after the company reported worse-than-expected financial results for the third quarter.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.